| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
0 | 0 | |||||
General and administrative | ||||||
0 | 0 | |||||
Restructuring expense | ||||||
0 | - | |||||
Total operating expenses | ||||||
0 | 0 | |||||
Finance (income) expense, net | ||||||
0 | 0 | |||||
Net loss and comprehensive loss | ||||||
0 | 0 | |||||
Basic and diluted loss per share | ||||||
-0.10 | -0.38 | |||||
Weighted average number of shares outstanding - basic and diluted | ||||||
37,099 | 26,337 | |||||